Divi's Laboratories Limited has informed the Exchange about signing of long-term manufacturing and supply agreement.
DIVISLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Divi's Laboratories has informed the stock exchanges that it has signed a long-term manufacturing and supply agreement. The company has not disclosed the counterparty, the contract value, or the duration of the agreement in this filing. Divi's is a major API and intermediate manufacturer, so such agreements typically relate to pharma contract manufacturing. Without further details, the financial impact cannot be quantified from this announcement alone.
Long-term supply agreements generally signal revenue visibility and business stability, but with no contract value or client details disclosed, the immediate stock impact is likely limited. Investors should watch for further disclosures about the size and scope of the deal.